Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Haermonics logo — Haermonics for safer open heart surgery. Our goal: saving 1...

Haermonics

Haermonics for safer open heart surgery. Our goal: saving 10,000 lives in 2030

Founded 2015 The Netherlands The Netherlands 12 employees Pre-Seed Health Care, Medical Devices

General Information

Company Name Haermonics
Founded Year 2015
Location The Netherlands The Netherlands
Founders / Decision Makers
Team member Team member
Employees 12
Industries Health Care, Medical Devices
Funding Stage Pre-Seed
Social

BounceWatch is an independent company data service, not affiliated with Haermonics. To contact Haermonics, visit haermonics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Haermonics compare?

A PDF of Haermonics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Haermonics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Haermonics

Haermonics, headquartered in The Netherlands, is strategically positioned within the Health Care and Medical Devices industries. Founded in 2015, the company is dedicated to enhancing the safety of open-heart surgeries with its slogan, "Haermonics for safer open heart surgery. Our goal: saving 10,000 lives in 2030".

The company is focused on offering a more economical alternative to traditional postoperative drainage products used in cardiac surgeries. The core technology developed by Haermonics provides an integrated solution for managing surgical blood loss and wound healing. It includes advanced features like targeted versatile therapy and smart clinical decision support that exceeds current standards. This technology aims to improve patient outcomes with enhanced safety and ease during post-surgical recovery.

Since its inception, Haermonics has attracted initial funding, having secured a Pre Seed Round investment on 01 September 2015 from NLC. As Haermonics explores further investment opportunities, it presents a compelling proposition for investors focusing on innovative health care solutions.

Business keywords: Health Tech Innovations, Cardiac Surgery, Surgical Blood Loss, Wound Healing, Clinical Trials, Perioperative Management

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round Undisclosed 1
NLC
01 Sep 2015
Seed Round Undisclosed 1
UvA VUmc AMC HvA Ventures Holding BV
UvA VUmc AMC HvA Ventures Holding BV
15 Mar 2015
Pre Seed Round Undisclosed 1
ACE (Amsterdam Center for Entrepreneurship)
ACE (Amsterdam Center for Entrepreneurship)
01 Nov 2014

Haermonics Alternatives & Competitors

Haermonics vs
Vascular Graft Solutions
Vascular Graft Solutions Israel

A new standard in coronary and peripheral bypass surgeries, arterial reconstruction and arteriovenou...

Series B
23 employees
B2B, Health Care
Haermonics vs
Centese
Centese United States

Inspired by surgeons. Innovated by Centese.

Series B
16 employees
Health Care, Medical Devices
Haermonics vs
CARDIVA
CARDIVA Spain

Innovation and Commitment

190 employees
Health Care, Manufacturing

FAQ About Haermonics

Haermonics for safer open heart surgery. Our goal: saving 10,000 lives in 2030
Haermonics was founded in 2015.
Haermonics is headquartered in The Netherlands.
Haermonics operates in Health Care and Medical Devices. Its work centres on Health Tech Innovations, Cardiac Surgery, Surgical Blood Loss and Wound Healing.
Haermonics has approximately 12 employees.
Haermonics has completed 3 funding rounds. The latest funding stage is Pre-Seed.
Top alternatives and competitors to Haermonics include Vascular Graft Solutions, Centese, CARDIVA, Allotex, Leith Medical, Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Haermonics and Vascular Graft Solutions are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Haermonics, https://bouncewatch.com/company/haermonics, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes